Search Results - "Shalansky, SJ"

Self-Reported Morisky Score for Identifying Nonadherence with Cardiovascular Medications by Shalansky, Stephen J, Levy, Adrian R, Ignaszewski, Andrew P

“…BACKGROUND: The Morisky medication adherence scale is a commonly used adherence screening tool. It is composed of 4 yes/no questions about past medication use…”
Get full text

Nonchemotherapy Drug-Induced Agranulocytosis: A Review of 118 Patients Treated with Colony-Stimulating Factors by Beauchesne, Marie-France, Shalansky, Stephen J.

“…To determine the role of growth factors in nonchemotherapy drug‐induced agranulocytosis, we reviewed 118 published reports of administration of…”
Get full text

Effect of number of medications on cardiovascular therapy adherence by Shalansky, SJ, Levy, AR

“…OBJECTIVE: Increasing regimen complexity is generally assumed to result in lower medication adherence, but there is conflicting evidence. This study determined…”
Get full text

Frequency of Heparin-Induced Thrombocytopenia in Critical Care Patients by Verma, Arun K., Levine, Marc, Shalansky, Stephen J., Carter, Cedric J., Kelton, John G.

“…The diagnosis of heparin‐induced thrombocytopenia (HIT) in critically ill patients is complicated by lack of information on the frequency of HIT relative to…”
Get full text

N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration by Shalansky, S J, Pate, G E, Levin, A, Webb, J G

“…Dose and route of administration of N-acetylcysteine are key factors to consider when evaluating whether this agent is effective in preventing radiocontrast…”
Get full text

Risk Markers for Thrombocytopenia in Critically Ill Patients: A Prospective Analysis by Shalansky, Stephen J., Verma, Arun K., Levine, Marc, Spinelli, John J., Dodek, Peter M.

“…Study Objective. To identify independent risk markers for thrombocytopenia in critically ill patients. Design. Prospective, observational study. Setting…”
Get full text

N-acetylcysteine for Prevention of Radiographic Contrast Material-Induced Nephropathy: Is the Intravenous Route Best? by Shalansky, Stephen J., Vu, Thanh, Pate, Gordon E., Levin, Adeera, Humphries, Karin H., Webb, John G.

“…Use of oral N‐acetylcysteine for preventing radiographic contrast material–induced nephropathy (RCIN) has become widespread, despite conflicting results from…”
Get full text

Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process by Shalansky, Stephen J, Virk, Roohina, Ackman, Margaret, Jackevicius, Cynthia, Kertland, Heather, Tsuyuki, Ross, Humphries, Karin

“…Access to new therapies in hospitals depends upon both clinical trial evidence and local Pharmacy and Therapeutics (P&T) committee approval. The process of…”
Get more information

Nitric Oxide for ARDS-What Is the Evidence? by Ferreira, Ema, Shalansky, Stephen J.

“…We critically reviewed English‐language articles indexed on MEDLINE from 1966–1998 and those cited in indexed articles describing or investigating…”
Get full text

Factors to Consider Before Discontinuing Heparin in Patients Who Develop Thrombocytopenia by Shalansky, Stephen J., Verma, Arun K., Levine, Marc

Get full text

Improved detection of drug-related problems in intensive care unit patients by Chen, R, Shalansky, S J

Get full text

Antibiotic interchange through educational interventions in a community hospital by Shalansky, S J

Get more information

Effect of flumazenil on benzodiazepine-induced respiratory depression by Shalansky, S J, Naumann, T L, Englander, F A

“…The ability of flumazenil to reverse benzodiazepine-induced respiratory depression is discussed through a review of the relevant literature. Flumazenil has…”
Get more information